Results 181 to 190 of about 30,112 (235)

Molecular and cytogenetic changes in ovarian carcinoma [PDF]

, 2001
Tapper, Johanna
core  

Proteomic analysis of ovarian carcinoma reveals diagnostic and prognostic biomarkers with histotype- and stage-specificity. [PDF]

J Ovarian Res
Werner L, Ittner E, Swenson H, Rönnerman EW, Mateoiu C, Kovács A, Dahm-Kähler P, Karlsson P, Parris TZ, Helou K.   +9 more
europepmc   +1 more source

Case Report: Synchronous primary high-grade appendiceal mucinous neoplasm and ovarian borderline mucinous cystadenoma: a rare case and diagnostic challenges. [PDF]

Front Oncol
Chen L, Liu Y.
europepmc   +1 more source

Genomic Landscapes of Endometrioid and Mucinous Ovarian Cancers and Morphologically Similar Tumor Types. [PDF]

Cancer Res Commun
Hallberg D, Eastman AC, Koul S, Bruhm DC, Papp E, Davenport S, Adleff V, Ferreira L, Niknafs N, Medina JE, Cristiano S, Hruban C, Fiksel J, Lebarbenchon KP, Aparicio L, Vulpescu NA, Kuo KT, Ahuja N, Drapkin R, Jung E, Kim SH, Eckert MA, Lengyel E, Nakayama K, Ayhan A, Shih IM, Wang TL, Lavie O, Rennert G, Easwaran H, Baylin SB, Press MF, Velculescu VE, Scharpf RB.   +33 more
europepmc   +1 more source

Letter to the Editor: "TP53 and KRAS co-mutations are associated with worse outcomes in mucinous ovarian carcinomas". [PDF]

Front Oncol
Feinstein L.
europepmc   +1 more source

Evaluation of Gynecological Mass Lesions Using Magnetic Resonance Imaging: An Observational Study. [PDF]

Cureus
Ghosh T, Choudhury S, Kumar A.
europepmc   +1 more source

Increased cytoplasmic and nuclear S100A6 expression is associated with improved prognosis in ovarian cancer. [PDF]

BMC Cancer
Farooq A, Akyuz EM, Cheah BW, Deen S, Martin SG, Finelli MJ, Storr S, McIntyre A.   +7 more
europepmc   +1 more source